The global malaria vaccines market is witnessing accelerated growth, fueled by increasing efforts to combat one of the world’s most persistent infectious diseases. Valued at USD 491.90 million in 2024, the market is projected to expand at a robust CAGR of 12.7% from 2025 to 2034, reaching approximately USD 1,619.87 million by 2034. Growing awareness, large-scale...